ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

AIDS Research Loan Repayment Program

January 10, 1992

IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies

January 7, 2011

TTF Increased Survival Compared To Chemotherapy

December 31, 2010

$3.3 Million For Retinoid Contract Awarded

October 14, 1977

Review Guidelines For Comprehensive Centers Drafted, NCAB To Consider at December Meeting

November 24, 1989

Cooperative Groups Pursue Contracts With Insurers, NCI Warns of Competition

June 14, 1996